ProfileGDS5678 / 1431195_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 24% 25% 24% 25% 24% 23% 23% 24% 43% 25% 24% 25% 24% 25% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.592224
GSM967853U87-EV human glioblastoma xenograft - Control 22.5735225
GSM967854U87-EV human glioblastoma xenograft - Control 32.5650624
GSM967855U87-EV human glioblastoma xenograft - Control 42.5274925
GSM967856U87-EV human glioblastoma xenograft - Control 52.5208124
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.6136123
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.5659323
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.5498424
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.9822643
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.5623525
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.553224
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.5552325
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.5665624
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.5634425